Epignostix
Epignostix is an AI-driven diagnostic tumor classifier founded in 2022.
B2X
Country
Founded Date
2022
Headquarters
Investors
Latest Funding Round Date
July 2, 2024
Latest Funding Round Amount (USD)
4,700,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
9,400,000
Official Website
Find more companies like Epignostix
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.